- Home
- TNC vs RCKT Comparison
TNC vs RCKT Comparison
Compare TNC & RCKT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | TNC | RCKT |
|---|---|---|
| Founded | 1870 | 1999 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.3B | 340.9M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | TNC | RCKT |
|---|---|---|
| Price | $75.38 | $3.53 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 2 | 14 |
| Target Price | ★ $113.50 | $29.12 |
| AVG Volume (30 Days) | 161.9K | ★ 2.0M |
| Earning Date | 11-03-2025 | 11-06-2025 |
| Dividend Yield | ★ 1.65% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 2.91 | N/A |
| Revenue | ★ $1,240,800,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $5.63 | N/A |
| P/E Ratio | $25.84 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $67.32 | $2.19 |
| 52 Week High | $90.44 | $13.35 |
Technical Indicators
Market Signals| Indicator | TNC | RCKT |
|---|---|---|
| Relative Strength Index (RSI) | 50.94 | 52.97 |
| Support Level | $73.77 | $3.19 |
| Resistance Level | $75.90 | $3.60 |
| Average True Range (ATR) | 1.63 | 0.19 |
| MACD | 0.15 | 0.01 |
| Stochastic Oscillator | 44.75 | 53.26 |
Price Performance
Historical ComparisonAbout TNC Tennant Company
Tennant Co is a manufacturer of floor cleaning equipment, wood flooring, and wood products. It operates in four geographic business units including North America; Latin America; Europe, Middle East, Africa; and Asia Pacific. The company offers products and solutions consisting of mechanized cleaning equipment, detergent-free, and other sustainable cleaning technologies, aftermarket parts and consumables, equipment maintenance and repair service, specialty surface coatings, and business solutions such as financing, rental and leasing programs, and machine-to-machine asset management solutions.
About RCKT Rocket Pharmaceuticals Inc.
Rocket Pharmaceuticals Inc is a late-stage biopharmaceutical company. It is focused on the development of gene therapies for rare and devastating pediatric diseases. The pipeline products of the company include RP-A501 for Danaon Disease, RP-L102 for Fanconi Anemia, RP-L201 for Leukocyte Adhesion, RP-L301 for Pyruvate Kinase Deficiency, and RP-L401 for Infantile Malignant Osteopetrosis. The Company has one reportable segment related to R&D and commercial readiness of its gene therapies.